Surgery in rheumatoid arthritis patients under anti-TNF-α therapy: What is the risk? [2]

Clinical Rheumatology

Volumn 26, Issue 8, 2007, Pages 1396-1397

  Wendling, Daniel ^a  

^a UNIVERSITY HOSPITAL OF BESANÇON   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; CORTICOSTEROID; DISEASE MODIFYING ANTIRHEUMATIC DRUG; ETANERCEPT; INFLIXIMAB; METHOTREXATE; PREDNISONE; TUMOR NECROSIS FACTOR ALPHA ANTIBODY;

FOLLOW UP; HUMAN; INCIDENCE; INFECTION RISK; JOINT PROSTHESIS; LETTER; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RHEUMATOID ARTHRITIS; RISK REDUCTION; SURGICAL RISK; WOUND HEALING;

ARTHRITIS, RHEUMATOID; BIOLOGICAL RESPONSE MODIFIERS; HUMANS; IMMUNOGLOBULIN G; POSTOPERATIVE COMPLICATIONS; RECEPTORS, TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR-ALPHA;

EID: 34447127417     PISSN: 07703198     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10067-007-0585-2     Document Type: Letter

References (10)

1. Corrao S, Pistone G, Arnone S, Calvo L, Scaglione R, Licata G (2007) Safety of etanercept therapy in patients undergoing surgery: Preliminary report. Clin Rheumatol DOI 10.1007/s10067-007-0534-0
2. Wendling D, Balblanc JC, Brousse A, Lohse A, LeHuédé G, Garbuio P et al (2005) Surgery under anti TNF-α therapy in rheumatoid arthritis: An observational study on 50 surgical procedures. Ann Rheum Dis 64(9):1378-1379
3. Bibbo C, Goldberg JW (2004) Infection and healing complications after elective orthopaedic foot and ankle surgery during tumor necrosis factor-alpha inhibition therapy. Foot Ankle Int 25(5):331-335
4. Joven BE, Rodriguez-Bachiller L, Matias M, De Juanes A, Garrido N, Mateo I (2005) Surgery in patients on anti-TNF therapy. Ann Rheum Dis 64(Suppl III):222
5. Den Broeder AA, Schraven T, De Jong E, De Rooij DRAM, Van den Hoogen FHJ (2005) Infectious complications in elective surgery in RA patients in the anti-TNF era: A retrospective study. Ann Rheum Dis 64(Suppl III):60
6. Shergy WJ, Phillips RM, Hunt RE, Hernandez J (2005) Infliximab and its impact on surgical outcomes in patients with rheumatoid arthritis. Ann Rheum Dis 64(Suppl III):465
7. Talwalker SC, Grennan DM, Gray J, Johnson P, Hayton MJ (2005) Tumour necrosis factor α antagonists and early postoperative complications in patients with inflammatory joint disease undergoing elective orthopaedic surgery. Ann Rheum Dis 64:650-651
8. Giles JT, Bartlett SJ, Gelber AC, Nanda S, Fontaine K, Ruffing V, Bathon JM (2006) TNF inhibitor therapy and risk of serious post operative orthopedic infection in rheumatoid arthritis. Arthritis Rheum 55(2):333-337
9. Ruyssen-Witrand A, Gossec L, Salliot C, Duclos M, Luc M, Guignard S, Dougados M (2005) Surgical procedures have a high complication rate in rheumatic patients receiving TNF alpha blockers: A systematic retrospective study of 770 patients. Arthritis Rheum 52(suppl):S339
10. Grennan DM, Gray J, Loudon J, Fear S (2001) Methotrexate and early postoperative complications in patients with rheumatoid arthritis undergoing elective orthopaedic surgery. Ann Rheum Dis 60(3):214-217